521 related articles for article (PubMed ID: 33978741)
1. Cancer-causing BRCA2 missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance.
Lee M; Shorthouse D; Mahen R; Hall BA; Venkitaraman AR
Nucleic Acids Res; 2021 Jun; 49(10):5588-5604. PubMed ID: 33978741
[TBL] [Abstract][Full Text] [Related]
2. Promotion of BRCA2-Dependent Homologous Recombination by DSS1 via RPA Targeting and DNA Mimicry.
Zhao W; Vaithiyalingam S; San Filippo J; Maranon DG; Jimenez-Sainz J; Fontenay GV; Kwon Y; Leung SG; Lu L; Jensen RB; Chazin WJ; Wiese C; Sung P
Mol Cell; 2015 Jul; 59(2):176-87. PubMed ID: 26145171
[TBL] [Abstract][Full Text] [Related]
3. DSS1 allosterically regulates the conformation of the tower domain of BRCA2 that has dsDNA binding specificity for homologous recombination.
Alagar S; Bahadur RP
Int J Biol Macromol; 2020 Dec; 165(Pt A):918-929. PubMed ID: 33011260
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.
Park JY; Singh TR; Nassar N; Zhang F; Freund M; Hanenberg H; Meetei AR; Andreassen PR
Oncogene; 2014 Oct; 33(40):4803-12. PubMed ID: 24141787
[TBL] [Abstract][Full Text] [Related]
5. Plasticity of BRCA2 function in homologous recombination: genetic interactions of the PALB2 and DNA binding domains.
Siaud N; Barbera MA; Egashira A; Lam I; Christ N; Schlacher K; Xia B; Jasin M
PLoS Genet; 2011 Dec; 7(12):e1002409. PubMed ID: 22194698
[TBL] [Abstract][Full Text] [Related]
6. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
Xia B; Sheng Q; Nakanishi K; Ohashi A; Wu J; Christ N; Liu X; Jasin M; Couch FJ; Livingston DM
Mol Cell; 2006 Jun; 22(6):719-729. PubMed ID: 16793542
[TBL] [Abstract][Full Text] [Related]
7. DSS1 is required for the stability of BRCA2.
Li J; Zou C; Bai Y; Wazer DE; Band V; Gao Q
Oncogene; 2006 Feb; 25(8):1186-94. PubMed ID: 16205630
[TBL] [Abstract][Full Text] [Related]
8. DSS1 and ssDNA regulate oligomerization of BRCA2.
Le HP; Ma X; Vaquero J; Brinkmeyer M; Guo F; Heyer WD; Liu J
Nucleic Acids Res; 2020 Aug; 48(14):7818-7833. PubMed ID: 32609828
[TBL] [Abstract][Full Text] [Related]
9. Increased chemosensitivity via BRCA2-independent DNA damage in DSS1- and PCID2-depleted breast carcinomas.
Gondo N; Sakai Y; Zhang Z; Hato Y; Kuzushima K; Phimsen S; Kawashima Y; Kuroda M; Suzuki M; Okada S; Iwata H; Toyama T; Rezano A; Kuwahara K
Lab Invest; 2021 Aug; 101(8):1048-1059. PubMed ID: 34031538
[TBL] [Abstract][Full Text] [Related]
10. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.
Yang H; Jeffrey PD; Miller J; Kinnucan E; Sun Y; Thoma NH; Zheng N; Chen PL; Lee WH; Pavletich NP
Science; 2002 Sep; 297(5588):1837-48. PubMed ID: 12228710
[TBL] [Abstract][Full Text] [Related]
11. Effect of the expression of BRCA2 on spontaneous homologous recombination and DNA damage-induced nuclear foci in Saccharomyces cerevisiae.
Spugnesi L; Balia C; Collavoli A; Falaschi E; Quercioli V; Caligo MA; Galli A
Mutagenesis; 2013 Mar; 28(2):187-95. PubMed ID: 23328489
[TBL] [Abstract][Full Text] [Related]
12. A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity.
Guidugli L; Pankratz VS; Singh N; Thompson J; Erding CA; Engel C; Schmutzler R; Domchek S; Nathanson K; Radice P; Singer C; Tonin PN; Lindor NM; Goldgar DE; Couch FJ
Cancer Res; 2013 Jan; 73(1):265-75. PubMed ID: 23108138
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
14. Effect of the overexpression of BRCA2 unclassified missense variants on spontaneous homologous recombination in human cells.
Balia C; Galli A; Caligo MA
Breast Cancer Res Treat; 2011 Oct; 129(3):1001-9. PubMed ID: 21671020
[TBL] [Abstract][Full Text] [Related]
15. DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells.
Gudmundsdottir K; Lord CJ; Witt E; Tutt AN; Ashworth A
EMBO Rep; 2004 Oct; 5(10):989-93. PubMed ID: 15359272
[TBL] [Abstract][Full Text] [Related]
16. Depletion of DSS1 protein disables homologous recombinational repair in human cells.
Kristensen CN; Bystol KM; Li B; Serrano L; Brenneman MA
Mutat Res; 2010 Dec; 694(1-2):60-4. PubMed ID: 20817001
[TBL] [Abstract][Full Text] [Related]
17. Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival.
Rezano A; Kuwahara K; Yamamoto-Ibusuki M; Kitabatake M; Moolthiya P; Phimsen S; Suda T; Tone S; Yamamoto Y; Iwase H; Sakaguchi N
BMC Cancer; 2013 Dec; 13():562. PubMed ID: 24289229
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic Disorder and Phosphorylation in BRCA2 Facilitate Tight Regulation of Multiple Conserved Binding Events.
Julien M; Ghouil R; Petitalot A; Caputo SM; Carreira A; Zinn-Justin S
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356684
[TBL] [Abstract][Full Text] [Related]
19. A second DNA binding site in human BRCA2 promotes homologous recombination.
von Nicolai C; Ehlén Å; Martin C; Zhang X; Carreira A
Nat Commun; 2016 Sep; 7():12813. PubMed ID: 27628236
[TBL] [Abstract][Full Text] [Related]
20. Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals.
Marston NJ; Richards WJ; Hughes D; Bertwistle D; Marshall CJ; Ashworth A
Mol Cell Biol; 1999 Jul; 19(7):4633-42. PubMed ID: 10373512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
